Wave Life Sciences Ltd. Quarterly Debt-to-equity in % from Q2 2016 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Wave Life Sciences Ltd. quarterly Debt-to-equity history and growth rate from Q2 2016 to Q2 2024.
  • Wave Life Sciences Ltd. Debt-to-equity for the quarter ending June 30, 2024 was 4.11K %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 4.11K +4.8K Jun 30, 2024
Q1 2024 -3.44K -1.89K -121% Mar 31, 2024
Q4 2023 -1.18K -207 -21.3% Dec 31, 2023
Q3 2023 -572 -12K -105% Sep 30, 2023
Q2 2023 -683 -2.33K -142% Jun 30, 2023
Q1 2023 -1.56K -3.69K -173% Mar 31, 2023
Q4 2022 -971 -1.47K -293% Dec 31, 2022
Q3 2022 11.5K +11.1K +2923% Sep 30, 2022
Q2 2022 1.64K +1.37K +489% Jun 30, 2022
Q1 2022 2.13K +1.81K +567% Mar 31, 2022
Q4 2021 502 +120 +31.3% Dec 31, 2021
Q3 2021 379 -54.8 -12.6% Sep 30, 2021
Q2 2021 279 -156 -35.9% Jun 30, 2021
Q1 2021 320 +79.2 +33% Mar 31, 2021
Q4 2020 382 +218 +133% Dec 31, 2020
Q3 2020 434 +272 +168% Sep 30, 2020
Q2 2020 435 +273 +169% Jun 30, 2020
Q1 2020 240 +74.3 +44.7% Mar 31, 2020
Q4 2019 164 +9.76 +6.31% Dec 31, 2019
Q3 2019 162 +64.3 +65.9% Sep 30, 2019
Q2 2019 162 +107 +197% Jun 30, 2019
Q1 2019 166 +145 +704% Mar 31, 2019
Q4 2018 155 +135 +695% Dec 31, 2018
Q3 2018 97.6 +80 +455% Sep 30, 2018
Q2 2018 54.4 +37.6 +224% Jun 30, 2018
Q1 2018 20.7 +5.59 +37.1% Mar 31, 2018
Q4 2017 19.5 +8.86 +83.7% Dec 31, 2017
Q3 2017 17.6 +10.2 +139% Sep 30, 2017
Q2 2017 16.8 +10.7 +178% Jun 30, 2017
Q1 2017 15.1 Mar 31, 2017
Q4 2016 10.6 Dec 31, 2016
Q3 2016 7.34 Sep 30, 2016
Q2 2016 6.04 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.